
Neuroscientist, Director Academic Affairs, Professor, Mentor, Drug Development @UFScripps.Co-Founder @MyosinTx, @in_pwn. @KauffmanFellows that stayed in science
Joined August 2018
- Tweets3K
- Following627
- Followers1.9K
- Likes5.1K
Courtney Miller, PhD retweeted
We're looking forward to participating as a selected presenting company in the Florida Venture Capital Conference in Miami next week #FVCC24MIAMI
Courtney Miller, PhD retweeted
WATCH: Palm Beach TV's Studio 33480 visits @UFScripps to interview @CMillerLab and Matthew Pipkin, Ph.D. about their cancer research, ahead of Wednesday's Outsmarting Cancer lecture. Details on how to get tickets in the thread. 🧵1/2 palmbeachcivic.org/studio-33… @PalmBeachCivic
Courtney Miller, PhD retweeted
New collaborative study w/ @dan_h_oconnor @meletislab @furthlab @CMillerLab
How do genes influence cognitive ability at the systems level?
Do sensory processing deficits associated with NDDs directly contribute to cognitive impairments? If so, how?
biorxiv.org/content/10.1101/…
Courtney Miller, PhD retweeted
Replying to @ezgi_hsuleyman @darnelr
Will be hiring at all levels to develop cutting-edge techniques, delve into wonderful synaptic biology, and thrive in a fun scientific community. DM me if interested and retweet! (2/3)
Courtney Miller, PhD retweeted
Incredibly excited to announce that I’ll be joining @UFScripps as an Assistant Professor in 2024! My lab will study synaptic RNA & mitochondrial regulation to unravel how the brain adapts to experiences and encodes memories. Thankful to @darnelr for endless support. (1/3)
Courtney Miller, PhD retweeted
(1/2) Calling all women entrepreneurs! Don’t miss the 2023 Women’s Entrepreneurship Symposium, hosted by @uspto. Join Mar. 1, 15, & 29 to learn about available resources & support for commercialization, & how to find or become a mentor for women inventors. uspto.gov/about-us/events/we…
Courtney Miller, PhD retweeted
"Women are too emotional" 🙄
"There aren't enough Black founders pitching" 🤨
"She doesn't have a proven track record" 😑
@DominicMadori debunks the myths used to try & excuse why women received 1.9% & Black founders raised just 1% of VC funds last year 👏🏾techcrunch.com/2023/01/20/de…
Courtney Miller, PhD retweeted
So cool!
Droplet-based transcriptome profiling of individual synapses | Nature Biotechnology nature.com/articles/s41587-0…
Courtney Miller, PhD retweeted
MAPS 2nd PTSD phase 3 succeeds, will be interesting to see the launch next year potentially. mapspublicbenefit.com/press-…
Courtney Miller, PhD retweeted
A challenge that every graduate student faces: how to read difficult research articles.
Here's how to understand research articles better using an AI-powered app (no cheating although it may feel like it 😀):
Courtney Miller, PhD retweeted
Whole-Brain Three-Dimensional Imaging of RNAs at Single-Cell Resolution biorxiv.org/cgi/content/shor… #biorxiv_neursci
Courtney Miller, PhD retweeted
Must read: a Congressional investigation of the FDA approval of Biogen's Alzheimer's drug Aduhelm, just dropped.
Three stories from @rachelcohrs, @adamfeuerstein, and @damiangarde.
1. statnews.com/2022/12/29/8-ke…
Courtney Miller, PhD retweeted
Ahaha omg
This Post is from an account that no longer exists. Learn more
Courtney Miller, PhD retweeted
A vexing question in psychiatry is how to translate genetic findings to clinical decision-making. We found that polygenicity is associated with a psychosis liability spectrum and clozapine prescribing, setting the stage for personalized psychosis treatment ja.ma/3HTzDIF
Courtney Miller, PhD retweeted
I'm reading @ZacharyBrennan @endpts newsletter & saw reminder that FDA has only approved 32 new drugs in '22. This is the lowest # in 6 yrs & 2nd lowest in 9 yrs. 41 in '14, 45 in '15, 46 in '17, 59 in '18, 48 in '19, 53 in '20, 50 in '21. 2012 saw the highest number since 1/n
Courtney Miller, PhD retweeted
DeCo-LACE employs #CryoEM for label-free detection of molecules across entire cell sections. elifesciences.org/articles/8…
Courtney Miller, PhD retweeted
In Science, researchers describe a class of transmembrane proteins that can help shuttle large drugs across the cell membrane, revealing a potential avenue to reach intractable intracellular targets.
📄: scim.ag/V1
#SciencePerspective: scim.ag/V2


























